Enhancement of viability of radiosensitive (PBMC) and resistant (MDA-MB-231) clones in low-dose-rate cobalt-60 radiation therapy.

Radiol Bras · 2015 · PMC4492568 · PMID 26185342

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

extremely significantp < 0.05actually significant

10 Gy dose at standard rates and at one fourth of the standard - The decrease in cell viability was extremely significant ( p < 0.05) at the 24-, 48- and 72-hour time, not only in relation to the non-irradiated control, but also in an equivalent manner for the two dose rates, as shown on Figure 3 .

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.